1Hall R I, Smith M S, Rocker G. The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations[J].Anesth Analg, 1997,85(4) :766-782.
2Bone R C,Balk R A,Cerra F B,et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis[J]. Chest, 1992,101 : 1644-1655.
3Bone R C. Immunologic Dissonance..A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome(SIRS) and the Multiple Organ Dysfunction Syndrome(MODS) [J]. Ann Intern Med, 1996,125 : 680-687.
4Gu Y J, Boonstra P W, Graaff R, et al. Pressure Drop, Shear Stress,and Activation of Leukocytes during Cardiopulmonary Bypass:a Comparison between Hollow Fiber and Flat Sheet Membrane Oxygenators[J]. Artif organs, 2000,24 (1) : 43-48.
5Collard C D, Gelman S. Pathophysiology, Clinical Manifestations,and Prevention of Ischemia-reperfusion Injury[J]. Anesthesiology, 2001,94(6) : 1133-1138.
6Kox W J, Volk T, Kox S N, et al. Immunomodulatory Therapies in Sepsis[J]. Intensive Care Med, 2000,26 : 124-128.
7Ueyama K, Nishimura K, Nishina T, et al. PMEA Coating of Pump Circuit and Oxygenator May Attenuate the Early Systemic Inflammatory Response in Cardiopulmonary Bypass Surgery[J]. Asaio J, 2004,50(4): 369-372.
8Brouicki R A, Backer C L, Baden H P, et al. Dexamethosone Reduce the Inflammatory Response to Cardiopulmonary Bypass in Children[J]. Ann Thorac Surg, 2000, 69 (5) : 1490- 1495.
9Buckberg G D. Update on Current Techniques of Myocardial Protection[J]. Ann Thorac Surg, 1995,60(4):805-809.
4Naik SK, Knight A, Elliott MJ. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation, 1991,84(suppl Ⅲ) : 422-431.
5Wang MJ, Chiu IS, Hsu CM, et al.Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg, 1996,61 : 651- 665.
6Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory responce to cardiopulmonary bypass in children. Anesthesiology, 1996, 86 : 965 - 976.
7Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion, 1991, 6 : 41 - 50.
8Anderson S, Gothberg S, Berggren H, et al. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg, 1993,56 : 1515- 1517.
9Roth-Isigkeit A, Borstel TV, Seyfarth M, et al. Perioperatlve serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoring cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution[J]. Clin Exp Immunol, 1999, 118(2) : 242-246.
10Kiuiau A, vandekerckhove F. Cytokines and their interaction with other inflammatory mediators in the pathogenesls of sepsis and septil shock [J]. Eur J clin Invest, 1991,221 (12) : 559-573.
